This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This AGTR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 211-240 amino acids from the Central region of human AGTR1.
AG2S antikoerper, AGTR1A antikoerper, AGTR1B antikoerper, AT1 antikoerper, AT1AR antikoerper, AT1B antikoerper, AT1BR antikoerper, AT1R antikoerper, AT2R1 antikoerper, AT2R1A antikoerper, AT2R1B antikoerper, HAT1R antikoerper, 1810074K20Rik antikoerper, AI551199 antikoerper, AT1a antikoerper, Agtr-1a antikoerper, Agtr1 antikoerper, Angtr-1a antikoerper, AT1A antikoerper, XAT-1 antikoerper, agtr1-A antikoerper, agtr1.2 antikoerper, AT1-R antikoerper, at1 antikoerper, AGTR1 antikoerper, Agtr-1b antikoerper, Angtr-1b antikoerper, agtr1 antikoerper, agtr1-a antikoerper, agtr1-b antikoerper, xAT antikoerper, angiotensin II receptor type 1 antikoerper, angiotensin II receptor, type 1a antikoerper, angiotensin II receptor type 1 S homeolog antikoerper, uncharacterized AGTR1 antikoerper, angiotensin II receptor, type 1b antikoerper, angiotensin II receptor type 1 L homeolog antikoerper, AGTR1 antikoerper, Agtr1a antikoerper, agtr1.S antikoerper, Agtr1 antikoerper, Agtr1b antikoerper, agtr1.L antikoerper
Hintergrund
Angiotensin II is a potent vasopressor hormone and a primary regulator of aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. It acts through at least two types of receptors. This gene encodes the type 1 receptor which is thought to mediate the major cardiovascular effects of angiotensin II. This gene may play a role in the generation of reperfusion arrhythmias following restoration of blood flow to ischemic or infarcted myocardium. It was previously thought that a related gene, denoted as AGTR1B, existed, however, it is now believed that there is only one type 1 receptor gene in humans. At least five transcript variants have been described for this gene. Additional variants have been described but their full-length nature has not been determined. The entire coding sequence is contained in the terminal exon and is present in all transcript variants. [provided by RefSeq].